PLGA (poly lactide-co-glycolide) nanoparticles loaded with annexin A2 shRNA vector can mediate long-term silencing of annexin A2 and are able to reduce tumor growth in xenograft models of prostate cancer [219]. Here, ANXA2 is linked to neoplasm.